Articles Related to DEXA
SARS-CoV-2 Pneumonia in A Preterm New born Treated Successfully by Dexamethasone
Data on illness in preterm infants due to severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is limited. Duration of viral shedding and treatment options including use of dexamethasone to treat SARS-CoV-2 pneumonia in preterm newborns are scarce and not-well reported. We are reporting SARS-COV-2 positive sick preterm twins vertically infected from SARS-COV-2 positive unvaccinated mother. Twin B initially tested negative at 24 & 48 hours of life (HOL) but subsequently tested positive at 72 HOL and developed SARS-COV-2 pneumonia and required a longer duration of respiratory support. We treated her with 10 days of dexamethasone and noted a good clinical response. To our knowledge, we are first to report the use dexamethasone in a premature newborn with SARS-COV-2 pneumonia. Additionally, the duration of viral shedding in both Twin A and Twin B was between 4-5 weeks.
Development and Validation of a Skin Fold Thickness Prediction Equation for Asian Indians Using Hydrodensitometry
Skin fold thickness prediction equations are widely used for estimating body fat percentage and thereby obesity. Equations to estimate body fat percentage for the Asian Indian population do not yet exist. The main purpose of this study was to develop and validate a new prediction equation for the estimation of body fat percentage in Asian Indian adults using anthropometric measurements (skin folds, circumference, bone breadth) and DEXA.
